Nasser Amri

Nasser Amri

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2023 in Inorganics
Verified
Journal Article
Open access
PDF file
SSSaad Shaaban
Saad Shaaban
YAYasair S. Al-Faiyz
Yasair S. Al-Faiyz
GAGhayah M Alsulaim
Ghayah M Alsulaim
Mohamed AlaasarMohamed Alaasar
Mohamed Alaasar
NANasser Amri
Nasser Amri
Aly AbdouAly Abdou
Aly Abdou
Herein we report the synthesis of organic selenide-based maleanilic and succinanilic acids in good yields (up to 95%). Their structural identities were elucidated by spectroscopic techniques (e.g., IR, 1H- & 13C-NMR, and MS). The ADMET analysis, molecule electrostatic potential map, DFT, and frontier molecular orbital were used to study the organoselenium compounds’ pharmacokinetics, drug-likeness characteristics, geometries, and chemical and electronic properties. Moreover, a molecular docking tool was employed to investigate the organic selenides’ ability to inhibit the SARS-CoV-2 Mpro target (PDB: 7BFB). Within this context, organic selenides exhibited promising binding affinities to the SARS-CoV-2 Mpro receptor in the following order (12 > 11 > 10 > 9 > 7 > 8). Furthermore, molecular dynamics simulations were also carried out for 200 ns to evaluate the exact behavior of the most active compound (12) within the Mpro binding pocket of SARS-CoV-2 compared with its co-crystallized inhibitor (Co).

16 June 2023 in Materials Chemistry and Physics
Verified
Journal Article
Closed access
AMA. Mindil
A. Mindil
HHHaseebul Hassan
Haseebul Hassan
MIMuhammad Waqas Iqbal
Muhammad Waqas Iqbal
AAAmir Muhammad Afzal
Amir Muhammad Afzal
NANasser Amri
Nasser Amri
NHN.M.A. Hadia
N.M.A. Hadia

19 August 2025 in Pharmaceutical Biology
Verified
Journal Article
Open access
Ameen A. Abu-HashemAmeen A. Abu-Hashem
Ameen A. Abu-Hashem
NANasser Amri
Nasser Amri
AEAhmed F. El-Sayed
Ahmed F. El-Sayed
Quinoline, isoxazole, and pyridothiazolopyrimidinone derivatives are novel compounds with significant biological activity, exhibiting anticancer properties and holding promising therapeutic applications. This investigation synthesized new heterocyclic compounds in high yields from quinoline-2-thioxo-pyridopyrimidinone and assessed their anticancer activities. Additionally, it conducted molecular docking, ADMET analysis, and molecular dynamics simulations. A new series of quinoline-pyridothiazolopyrimidine derivatives has been synthesized using advanced techniques. The structures of the new compounds were confirmed using IR, NMR, MS and elemental analysis. All compounds were tested in vitro for their anticancer activity. Isoxazole and thiazolopyridopyrimidinones displayed the highest activity against several cancer cell lines. Docking simulations revealed that compounds 5d, 5e, 11a, and 11b exhibited favorable binding energies and effectively interacted with the active sites of the EGFR, CDK2, ERα, and VEGFR receptors. The ADMET analysis of these compounds demonstrated compliance with Pfizer's rules. Molecular dynamics simulations confirmed the stability of complexes formed by compounds 5d, 11a, and 11b with CDK2, ERα, VEGFR, and EGFR. The root mean square deviation (RMSD) values were recorded, while the root mean square fluctuation (RMSF) values ranged from 0.10 to 0.6 nm. The solvent-accessible surface area (SASA) values were measured to be between 135-145 nm2, 125-130 nm2, 155-165 nm2, and 160-175 nm2. The cytotoxicity (IC50) and selectivity index are presented in Tables. Molecular docking analyses showed that compounds 5d, 5e, 11a, and 11b demonstrated significant binding energies. These consistent results support the notion that both practical and theoretical studies align regarding the anticancer properties of these new compounds. Furthermore, these findings emphasize the potential of these compounds in ongoing drug development efforts.

14 March 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
MPMehul P. Parmar
Mehul P. Parmar
DVDisha P. Vala
Disha P. Vala
SBSavan S. Bhalodiya
Savan S. Bhalodiya
DUDipti B. Upadhyay
Dipti B. Upadhyay
CPChirag D. Patel
Chirag D. Patel
Prof. Dr. Hitendra M Patel, FRSCProf. Dr. Hitendra M Patel, FRSC
Prof. Dr. Hitendra M Patel, FRSC
Twenty-three new derivatives of (R/S)-TDHPM-5-carboxanilide have been synthesized with up to 99% yield. All racemates were separated using chiral HPLC (Prep LC) which provided up to 99.99% purity. AC was determined using circular dichroism spectra.

29 January 2024 in Molecules
Verified
Journal Article
Open access
PDF file
Ameen A. Abu-HashemAmeen A. Abu-Hashem
Ameen A. Abu-Hashem
OHOthman Hakami
Othman Hakami
NANasser Amri
Nasser Amri
Yousef MukhrishYousef Mukhrish
Yousef Mukhrish
AAAhmed A M Abdelgawad
Ahmed A M Abdelgawad
This review article discusses the recent progress in synthesizing seven-membered ring 1,3,5-triazepine and benzo[f][1,3,5]triazepine derivatives. These derivatives can be either unsaturated, saturated, fused, or separated. This review covers strategies and procedures developed over the past two decades, including cyclo-condensation, cyclization, methylation, chlorination, alkylation, addition, cross-coupling, ring expansions, and ring-closing metathesis. This review discusses the synthesis of 1,3,5-triazepine derivatives using nucleophilic or electrophilic substitution reactions with various reagents such as o-phenylenediamine, 2-aminobenzamide, isothiocyanates, pyrazoles, thiazoles, oxadiazoles, oxadiazepines, and hydrazonoyl chloride. This article systematically presents new approaches and techniques for preparing these compounds. It also highlights the biological importance of benzo[f][1,3,5]triazepine derivatives, which have been used as drugs for treating nervous system diseases. This review aims to provide researchers with the necessary information to create and develop new derivatives of these compounds as quickly as possible.

6 September 2024 in Applied Physics A
Verified
Journal Article
Closed access
PDF file
MEMehrose
Mehrose
MQMuhammad Azam Qamar
Muhammad Azam Qamar
SASyed Ali
Syed Ali
Mohd ImranMohd Imran
Mohd Imran
AFAhmad Farhan
Ahmad Farhan
NANasser Amri
Nasser Amri